Accuray Incorporated (NASDAQ:ARAY) Insider Sells $30,832.50 in Stock

Accuray Incorporated (NASDAQ:ARAY) insider Andrew J. Kirkpatrick sold 8,222 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $3.75, for a total transaction of $30,832.50. Following the completion of the transaction, the insider now owns 232,414 shares in the company, valued at $871,552.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Accuray stock opened at $3.81 on Monday. The firm has a market cap of $335.37 million, a price-to-earnings ratio of -13.61 and a beta of 1.86. Accuray Incorporated has a 52-week low of $3.00 and a 52-week high of $5.40. The company has a debt-to-equity ratio of 3.06, a quick ratio of 1.03 and a current ratio of 1.71. The business’s 50 day simple moving average is $3.79.

Accuray (NASDAQ:ARAY) last released its earnings results on Tuesday, April 23rd. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.03. The company had revenue of $103.22 million for the quarter, compared to analyst estimates of $104.02 million. Accuray had a negative net margin of 3.85% and a negative return on equity of 25.91%. Analysts predict that Accuray Incorporated will post -0.16 EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. Norges Bank purchased a new stake in shares of Accuray in the 4th quarter valued at approximately $3,287,000. D. E. Shaw & Co. Inc. increased its position in shares of Accuray by 58.2% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,015,496 shares of the medical equipment provider’s stock valued at $6,873,000 after purchasing an additional 741,493 shares during the last quarter. Acadian Asset Management LLC increased its position in shares of Accuray by 429.2% in the 1st quarter. Acadian Asset Management LLC now owns 746,860 shares of the medical equipment provider’s stock valued at $3,562,000 after purchasing an additional 605,743 shares during the last quarter. Cadence Capital Management LLC purchased a new stake in shares of Accuray in the 1st quarter valued at approximately $2,307,000. Finally, Millennium Management LLC increased its position in shares of Accuray by 59.7% in the 4th quarter. Millennium Management LLC now owns 1,257,268 shares of the medical equipment provider’s stock valued at $4,287,000 after purchasing an additional 470,087 shares during the last quarter. Institutional investors own 81.24% of the company’s stock.

Several brokerages have recently commented on ARAY. BidaskClub upgraded shares of Accuray from a “sell” rating to a “hold” rating in a report on Wednesday, April 24th. BTIG Research reiterated a “hold” rating on shares of Accuray in a report on Wednesday, April 24th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $5.13.

About Accuray

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.

Featured Article: What Does Beta Mean In Stock Selection

Insider Buying and Selling by Quarter for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter.